Phase II Study of a Combination of Irinotecan and S-1 in Patients with Advanced Gastric Cancer (OGSG0002)

Publisher： Karger

E-ISSN： 1423-0232|73|1-2|65-71

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.1-2, 2008-03, pp. : 65-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Phase II Study of Biweekly Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 49-52

Karger

Access to resources Recommend Favorite

Phase I Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 37-41

Karger

Access to resources Recommend Favorite